🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jianxin Wang

Roswell Park Comprehensive Cancer Center

ORCID: 0000-0002-0998-4996
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Identifying protein complexes based on density and modularity in protein-protein interaction network”.

Identifying protein complexes based on density and modularity in protein-protein interaction network

BMC Systems Biology(2013)10.1186/1752-0509-7-s4-s12
N/A
1.5DataRank · unranked
27 citations

Jianxin Wang, Min Li, Lusheng Wang, Jun Ren

Discovery and identification of a novel PI3K inhibitor with enhanced CDK2 inhibition for the treatment of triple negative breast cancer

Bioorganic Chemistry(2023)10.1016/j.bioorg.2023.106779
N/A
0.449DataRank · unranked
19 citations

Menghui Wang, Yimin Gong, Mingli Deng, Yun Ling, Qingquan Li +3 more

Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle

Nature Communications(2025)10.1038/s41467-025-56674-4
N/A
0DataRank · unranked
35 citations

Jianxin Wang, Michelle Roti, Yin Wan, Adam P. Dommer, Hanna R. Rosenheck +11 more

p16 expression confers sensitivity to CDK2 inhibitors in cyclin E1–driven ovarian cancers

Science Signaling(2025)10.1126/scisignal.adv0415
N/A
0DataRank · unranked
4 citations

Lotte P. Watts, Brianna Fernandez, Nasreen Marikar, Jianxin Wang, Erik S. Knudsen +3 more

The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer

Cancer Research(2024)10.1158/0008-5472.can-23-2504
N/A
0DataRank · unranked
48 citations

Jianxin Wang, Costakis Frangou, Yin Wan, Andrew Dynka, Hanna R. Rosenheck +5 more

p16 expression confers sensitivity to CDK2 inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.02.10.637344
N/A
0DataRank · unranked
4 citations

Lotte P. Watts, Brianna Fernandez, Jianxin Wang, Erik S. Knudsen, Agnieszka K. Witkiewicz +2 more

Targeting FGFR4 Abrogates HNF1A-driven Metastasis in Pancreatic Ductal Adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.02.06.636643
N/A
0DataRank · unranked
1 citations

K. Humphrey, Eduardo Cortes Gomez, Jianxin Wang, Michael E. Feigin, Agnieszka K. Witkiewicz +3 more

Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma

Molecular Cancer(2025)10.1186/s12943-025-02408-5
N/A
0DataRank · unranked
3 citations

Kennedy S. Humphrey, Eduardo Cortes Gomez, Jianxin Wang, Vishnu Kumarasamy, Yin Wan +7 more

Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0369
N/A
0DataRank · unranked
7 citations

Jianxin Wang, Thomas N. O’Connor, Stephanie L. Tzetzo, Katerina V. Gurova, Erik S. Knudsen +2 more